Alloy Pitch Deck: Slide-by-Slide Breakdown

The Narrative: Reclaiming the Menopause Conversation

Alloy’s pitch deck is less about complex medical technology and more about cultural repositioning. In 2021, the 'femtech' space was booming, but much of the venture capital was flowing toward fertility and menstruation. Alloy identified a massive gap: the 55 million women in the U.S. experiencing menopause. The deck’s primary achievement is taking a topic often shrouded in 'shame' and 'misinformation' and turning it into a high-growth D2C opportunity.

Slides 1-2: The Vision and the Demographic

The deck opens with a high-energy cover slide featuring a woman in her 40s in a dynamic pose. This immediately signals that Alloy is not a 'clinical' or 'depressing' brand. The subtitle, "A radically honest, holistic solution for women's health after 40," sets the tone. Slide 2 reinforces this with the statement, "We believe women over forty deserve to feel fantastic." By using high-quality lifestyle photography, they are signaling to investors that they understand the aesthetic and emotional language of their target customer.

Slides 3-5: The Problem Triple-Threat

Alloy breaks the problem into three distinct parts. Slide 3 provides the scale: 55 million women in the U.S. are in menopause and lack solutions. Slide 4 addresses the 'why'—citing 20 years of misinformation stemming from a misinterpreted 2001 study on Menopausal Hormonal Treatment (MHT). This is a crucial slide because it explains the market inefficiency; women want treatment, but fear and lack of regulation have pushed 51% of them toward unregulated 'Complementary and Alternative Medicine' (CAM). Slide 5 adds the emotional layer, noting that menopause is "isolating and lonely," and that Gen X is ready to bring this conversation online just as they did with platforms like The Knot and Baby Center.

Slides 6-10: The Purpose and Value Proposition

After the 'Introducing Alloy' transition on Slide 6, Slide 7 defines their purpose: helping women "age healthfully." Slide 8 (and its duplicate on Slide 10) uses a Venn diagram to show their three pillars: Menopause trained physicians, Connection to community, and Evidence-based solutions. Slide 9 is a strategic 'wedge' slide. It admits they can't solve everything at once, so at launch, they are "targeting the most severe symptoms of menopause: hot flashes." This focus is a positive sign for investors, showing a disciplined go-to-market strategy.

Slides 11-12: The Product and User Experience

Slide 11 outlines the "Alloy Offering" in four steps: a quiz, an online medical assessment, home delivery of prescriptions/OTC products, and ongoing care via unlimited messaging. This is a standard D2C telehealth funnel, popularized by companies like Hims or Ro. Slide 12 provides UI/UX mockups, showing a clean, mobile-first interface that uses bold typography and relatable imagery. The messaging on the screen— "Over 40? Don't feel like yourself? We got you." —is direct and empathetic.

Slides 13-15: Clinical Credibility and Science

Because Alloy is dealing with hormone treatments, medical authority is non-negotiable. Slide 13 introduces Sharon Malone, MD , and notes that all doctors on the platform will be NAMS-certified . Slide 14 gets specific about the science, listing FDA-approved bioidentical estradiol and micronized progesterone. It also includes a significant market stat: "The MHT Market Size is poised to reach $39.6 Billion by 2027 Globally." Slide 15 focuses on the 'Community' aspect, promising monthly Q&As and tailored emails, which serves as a retention strategy beyond just selling pills.

Slides 16-17: Competition and Expansion

Slide 16 is the 'moat' slide. Alloy claims to be the "only menopause telehealth solution to ship prescriptions nationally" and highlights a "25%-75%" pricing advantage. This is a bold claim that suggests they have optimized their supply chain or are willing to operate on thinner margins to capture market share. Slide 17 shows the 'Additional Market Opportunities,' including mental health ($225B spending), sexual health ($11B market), and supplements ($45B market). This tells investors that while they are starting with hot flashes, the LTV (Lifetime Value) of the customer could be enormous as they expand into other categories.

Slides 18-21: The Team and the Kairos Pedigree

Slide 18 lists the Seed Funding Milestones, which are refreshingly specific: scaling to 4 engineers and 5 marketing staff, and transitioning tech in-house by Q1 2022. Slide 19 features the Advisory Board, notably Bobbi Brown . Having a household name in beauty and lifestyle on the board is a massive signal of brand potential. Slide 20 is perhaps the most important for the 'close.' It reveals that Alloy is part of the Kairos family . It lists sister companies like Rhino, Bilt, and Little Spoon, noting that the portfolio's collective annualized revenue rose from $78M in 2Q20 to $238M in 2Q21 . This 'guilt by association' with high-growth winners likely did a lot of the heavy lifting in the $3.3M raise.

What Works in the Alloy Deck

Demographic Clarity: They don't just say 'women.' They say 'Gen X women over 40' and explain why this specific cohort is ready for a digital solution. · Visual Identity: The deck looks like a high-end magazine. It avoids the 'medical blue' tropes of healthcare and uses warm, sophisticated colors that appeal to their target buyer. · The Wedge Strategy: Focusing on hot flashes first (Slide 9) gives the company a clear, measurable starting point rather than trying to boil the ocean of 'aging.' · Institutional Credibility: Leveraging the Kairos portfolio metrics (Slide 20) provides a safety net for investors, suggesting that the founders have access to a proven growth playbook.

What is Missing from the Alloy Deck

Unit Economics: While they mention a pricing advantage, there is no mention of Customer Acquisition Cost (CAC) vs. Lifetime Value (LTV). For a D2C company, these are the most important numbers. · Detailed Competitive Matrix: They claim to be 25-75% cheaper, but they don't name the competitors or show a feature-by-feature comparison. · The Founders: Interestingly, the deck focuses on the Advisory Board and the Kairos family but doesn't have a dedicated slide for the actual day-to-day founders and their specific backgrounds. · Regulatory Roadmap: Shipping prescriptions nationally is complex. The deck mentions they do it, but doesn't explain the legal or pharmacy infrastructure behind it.

What Other Founders Should Copy

The 'Problem Part 1, 2, 3' Structure: Breaking a complex problem into scale, misinformation, and emotional impact makes the solution feel inevitable. · High-Profile Advisors: If you are in a consumer-facing vertical, a single 'name' advisor like Bobbi Brown can be worth more than five pages of technical specs. · The 'Family' Slide: If you are part of an incubator or have a lead investor with other winners, don't be afraid to show their growth stats. It proves you are in an ecosystem that knows how to scale. · Bold Typography: In a sea of boring decks, Alloy's use of large, serif fonts and high-contrast layouts makes the deck memorable and professional.